Comera Life Sciences Holdings Inc (CE) (CMRAW)
USOTC
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD ($) | USD ($) | |
Return on Assets (%) | -16.618 | -274.729 |
Return on Equity (%) | -30.15 | 3965.049 |
Return on Invested Capital (%) | -242.243 | -661.692 |
Operating Margin (%) | -250.625 | -2841.074 |
Net Profit Margin (%) | -250.625 | -2903.318 |
Book Value Per Share | N/A | -0.103 |
Earnings Per Share | N/A | -1.1 |
Cash Per Share | N/A | 0.027 |
Working Capital Per Share | N/A | -0.119 |
Operating Profit Per Share | N/A | 0.031 |
EBIT Per Share | N/A | -1.078 |
EBITDA Per Share | N/A | -1.078 |
Free Cash Flow Per Share | N/A | -1.104 |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
Current Ratio | N/A | N/A |
Quick Ratio | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A |
Shares Outstanding | N/A | 16.71M |
Market Cap | 1.67k |
Price to Earnings Ratio | -0.04 |
Price to Sales Ratio | 1.06 |
Price to Cash Ratio | 1.49 |
Price to Book Ratio | -0.39 |
Dividend Yield | - |
Shares Outstanding | 16.71M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.